Lack of a role of the interferon-stimulated response element-like region in interferon α-induced suppression of hepatitis B virus in vitro

被引:17
作者
Rang, A [1 ]
Heise, T [1 ]
Will, H [1 ]
机构
[1] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-20251 Hamburg, Germany
关键词
D O I
10.1074/jbc.C000584200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The antiviral effect of interferon-alpha (IFN alpha) on hepatitis B virus (HBV) is well documented in vitro and in vivo, but the mechanisms involved are elusive. Recently, an interferon-stimulated response like element (ISRE) competent for binding of interferon-stimulated gene Factor-3 gamma (p48) has been identified in the HBV enhancer I region. Mutation of this element was shown to abrogate IFN alpha -mediated reduction of HBV X-gene promoter-driven reporter gene expression. This suggested a role of the ISRE and of p48 in IFN alpha -induced antiviral activity against productive HBV infection. Here, we analyzed the antiviral effect of both IFNa and enhanced p48 expression on complete HBV genomes containing the wildtype or mutated ISRE. In human hepatoma cells transfected with both genomes, viral RNA and replicative intermediates were reduced by IFNa treatment to a similar degree. Enhanced p48 expression increased IFN alpha -induced suppression of HBV RNA significantly from 75 +/- 22.5% to 46 +/- 9.8%, but this was independent of the integrity of the ISRE-like region. These data imply that p48 neither mediates the antiviral activity of IFNa against HBV nor down-regulates enhancer I activity by binding directly to the HBV ISRE-like region, but rather argue for an indirect role of p48,
引用
收藏
页码:3531 / 3535
页数:5
相关论文
共 24 条
[1]   Inhibition of the expression of hepatitis A and B viruses (HAV and HBV) proteins by interferon in a human hepatocarcinoma cell line (PLC/PRF/5) [J].
Berthillon, P ;
Crance, JM ;
Leveque, F ;
Jouan, A ;
Petit, MA ;
Deloince, R ;
Trepo, C .
JOURNAL OF HEPATOLOGY, 1996, 25 (01) :15-19
[2]   The enhancer I core region contributes to the replication level of hepatitis B virus in vivo and in vitro [J].
Bock, CT ;
Malek, NP ;
Tillmann, HL ;
Manns, MP ;
Trautwein, C .
JOURNAL OF VIROLOGY, 2000, 74 (05) :2193-2202
[3]   TYPE-I INTERFERONS INHIBIT HEPATITIS-B VIRUS-REPLICATION AND INDUCE HEPATOCELLULAR GENE-EXPRESSION IN CULTURED LIVER-CELLS [J].
CASELMANN, WH ;
MEYER, M ;
SCHOLZ, S ;
HOFSCHNEIDER, PH ;
KOSHY, R .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (05) :966-971
[4]   JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS [J].
DARNELL, JE ;
KERR, IM ;
STARK, GR .
SCIENCE, 1994, 264 (5164) :1415-1421
[5]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[6]   INHIBITION OF HEPATITIS-B VIRUS IN TISSUE-CULTURE BY ALPHA-INTERFERON [J].
DAVIS, MG ;
JANSEN, RW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (12) :2921-2924
[7]   Stat1 associates with c-kit and is activated in response to stem cell factor [J].
DeBerry, C ;
Mou, S ;
Linnekin, D .
BIOCHEMICAL JOURNAL, 1997, 327 :73-80
[8]   The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN-gamma activation site and an imperfect IFN-stimulated response element which mediate type I IFN inducibility [J].
Grotzinger, T ;
Jensen, K ;
Will, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (41) :25253-25260
[9]   INTERACTION OF INTERFERON-ALPHA WITH INTERLEUKIN-1-BETA OR TUMOR-NECROSIS-FACTOR-ALPHA ON HEPATITIS-B VIRUS ENHANCER ACTIVITY [J].
HAMASAKI, K ;
NAKATA, K ;
NAKAO, K ;
MITSUOKA, S ;
TSUTSUMI, T ;
KATO, Y ;
SHIMA, M ;
ISHII, N ;
TAMAOKI, T ;
NAGATAKI, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 183 (02) :904-909
[10]   INTERFERON INHIBITS HEPATITIS-B VIRUS-REPLICATION IN A STABLE EXPRESSION SYSTEM OF TRANSFECTED VIRAL-DNA [J].
HAYASHI, Y ;
KOIKE, K .
JOURNAL OF VIROLOGY, 1989, 63 (07) :2936-2940